The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Charles L. Crespi sits on this spectrum.
This scientist: 119 publications — 12th percentile
12% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Charles L. Crespi sits on this spectrum.
This scientist: 60 D-Index — 41st percentile
41% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Charles L. Crespi is a researcher primarily affiliated with Corning (United States). Their research spans several fields within medicine, with a focus on pharmacology and toxicology. The scientist's work notably intersects with oncology, pediatrics, perinatology and child health, and pharmacology.
The scientist's main research topics include drug transport and resistance mechanisms, pharmacological effects and toxicity studies, and pharmacogenetics and drug metabolism. These areas reflect an emphasis on understanding how drugs interact with biological systems, how genetic factors influence drug metabolism, and mechanisms contributing to drug resistance.
Among their recent published works is the paper titled "BindingDB Entry 50004711: Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1,1-dimethylethylaminocarbonyl)-4-[(furo[2,3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethylpentanamide and P-glycoprotein by valspodar in gene transfectant systems", published in 2020 in PubMed.
Frequent co-authors collaborating with Charles L. Crespi include:
Publication venues regularly featuring Crespi's work include:
Charles L. Crespi's research reflects a comprehensive approach to studying critical aspects of pharmacology and medicine, focusing on how drugs are metabolized and how resistance mechanisms develop. Their published work contributes to the scientific understanding relevant to both clinical and pharmacological fields.
T Nguyen;D Brunson;C L Crespi;B W Penman
John L. Durant;William F. Busby;Arthur L. Lafleur;Bruce W. Penman
Thomas K. H. Chang;Georg F. Weber;Charles L. Crespi;David J. Waxman
Charles L. Crespi;Vaughn P. Miller;Bruce W. Penman
Fumihiro Sata;Andrea Sapone;Guillermo Elizondo;Penny Stocker
Partha Roy;Li J. Yu;Charles L. Crespi;David J. Waxman
Charles L. Crespi;Vaughn P. Miller
William F. Busby;Joseph M. Ackermann;Charles L. Crespi
Erin L. Code;Charles L. Crespi;Bruce W. Penman;Frank J. Gonzalez
Namrata Bahadur;Julian B.S Leathart;Elaine Mutch;Dorothy Steimel-Crespi
Charles L. Crespi;Bruce W. Penman;Harry V. Gelboin;Frank J. Gonzalez
David M. Stresser;Andrew P. Blanchard;Stephanie D. Turner;John C. L. Erve
Xiaoxi Chen;Anthony Murawski;Karishma Patel;Charles L. Crespi
Karthik Venkatakrishnan;Lisa L. von Moltke;Michael H. Court;Jerold S. Harmatz
Magang Shou;Kenneth R. Korzekwa;Charles L Crespi;Frank J. Gonzalez
Charles L. Crespi;Bruce W. Penman;Julian A.E. Leakey;Michael P. Arlotto
Sandra Coecke;Hans Ahr;Bas J. Blaauboer;Susanne Bremer
Frank J. Gonzalez;Charles L. Crespi;Harry V. Gelboin
Charles L. Crespi;Frank J. Gonzalez;Dorothy T. Steimel;Thomas R. Turner
Charles L. Crespi;Bruce W. Penman;Dorothy T. Steimel;Harry V. Gelboin
If you think any of the details on this page are incorrect, let us know.
The Ohio State University
Queen Mary University of London
Monash University
University of New England
Royal Military College of Canada
KU Leuven
University of Massachusetts Amherst
Baylor College of Medicine
University of Maryland, Baltimore County
Northern Arizona University
Chinese Academy of Sciences
Yale University
University of Queensland
University of Arizona
Harbin Institute of Technology
University of Konstanz